Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

One-two Combination Floors Cancer

Published: Wednesday, June 26, 2013
Last Updated: Wednesday, June 26, 2013
Bookmark and Share
A new tag-team approach to combating a type of skin cancer is showing early promise in the lab.

The scientists in Oxford and Spain investigated a two-drug combination to better target cancer cells in melanoma.

The approach uses one drug to drive melanoma cancer cells that are invasive to become sensitive to a second drug. This second drug is a new compound that is activated very specifically in melanoma cells and not other cells in the body.

'Importantly, because the new drug is only activated in melanoma cells, there should be no side effects,' says Professor Colin Goding from the Ludwig Institute for Cancer Research at the University of Oxford.

The first drug, methotrexate, is an existing one that is currently used for diseases such as arthritis and psoriasis. The researchers found that methotrexate stops melanoma cells spreading to other parts or the body, and also sensitises the cells to the second drug, a new compound called TMECG, which kills the cancer cells.

When given alone, neither drug has any effect. But together, the researchers show that the two drugs kill melanoma cells very effectively in the laboratory and also in animal models – including cancer cells that are resistant to current therapies.

The research team – jointly led by Professor Goding and Professor José Neptuno Rodriguez-López from the University of Murcia in Spain – have shown the potential of the technique in human cells in the lab and in mice. They have published their findings in the journal Cancer Cell.

'The work is still at an early stage,' cautions Professor Goding. 'Although this combination treatment works very effectively in animals, we still need to improve the stability of the new drug in the blood to make it effective in patients. We also need to check that there is no toxicity associated with the new drug, though our preliminary results look very good.'

The researchers believe that it will be combinations of treatment approaches like this one that will help floor cancer, and deal with the great problem of tumours acquiring resistance to cancer therapies.

'The major problem with cancers is their capacity to become resistant to therapy and to spread to many parts of the body,' explains Professor Goding. 'Resistance is caused by there being different kinds of cancers cells within tumours, some of which may be resistant to therapy.'

Melanoma is a rare and serious type of cancer that begins in the skin and can spread to other organs in the body. The most common sign of melanoma is the appearance of a new mole or a change in an existing mole. Melanoma caught early can be treated very effectively by surgery. But unfortunately there is no long-term effective therapy once the disease has spread.

'There is a new drug called vemurafenib that gives a good response for the 50% of patients whose cancers have a mutation in the BRAF gene, but resistance occurs within some months,' says Professor Goding. 'Chemotherapy is largely ineffective, and though there is some success with a new form of immunotherapy, this is still at a very early stage.'

He outlines how cancers like melanoma may need to be treated in future: 'We envisage that treating cancer must be done using combinations of therapies that work by completely different mechanisms, such that cells resistant to one therapy would be sensitive to the other.

'We may need to give these combinations sequentially or in combination. So, if therapy A kills the vast majority of cancer cells there will be only few left that are resistant to therapy A, but should still be sensitive to therapy B. Since after therapy A there are few cells that survive, there is much less chance of resistance to therapy B occurring.

'In other words to treat cancer successfully we may need to think about the way we treat a bacterial infection, with combinations of antibiotics. Combinations of anti-cancer therapies may have much more success than giving one treatment alone.'

The researchers hope that the new strategy they have identified will form one treatment approach that, in combination with others, may contribute to a successful anti-melanoma therapy that is effective in the long-term.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Tuesday, November 24, 2015
Seeking the Right Prescription in Fight Against Antibiotic Resistance
Researchers at the University of Oxford have received funding to look at ways to improve the prescribing of antibiotics.
Monday, November 23, 2015
£17M Project Launched to Develop HIV Vaccine
A new €23 million (£17 million) initiative to accelerate the search for an effective HIV vaccine has begun.
Wednesday, November 11, 2015
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
Tuesday, November 10, 2015
Mini DNA Sequencer’s Data Belies its Size
A miniature DNA sequencing device that plugs into a laptop and was developed by Oxford Nanopore has been tested by an open, international consortium, including Oxford University researchers.
Tuesday, October 20, 2015
Microbe Artwork Shows The Limits Of Antibiotics
An Oxford University research fellow has been creating art using bacteria found in the human gut and harvested from faecal samples.
Tuesday, September 29, 2015
Funding Boost for Diabetes Research
Programme of research could be a game-changer for people with Type 1 diabetes and insulin-dependent Type 2 diabetes.
Friday, July 24, 2015
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
Thursday, July 16, 2015
New Insight into Recombination and Sex Chromosomes
Not only does the platypus have some odd physical features, an updated version of its genome has also underscored the unusual genetic characteristics that it harbors.
Tuesday, May 12, 2015
Protein Clue To Sudden Cardiac Death
A protein has been shown to have a surprising role in regulating the 'glue' that holds heart cells together, a finding that may explain how a gene defect could cause sudden cardiac death.
Tuesday, February 17, 2015
Oxford Vaccine Group Begins First Trial of New Ebola Vaccine
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).
Wednesday, January 07, 2015
New Vaccine Generates Strong Immune Response Against Hepatitis C
A new hepatitis C vaccine has shown promising results in an early clinical trial at Oxford University, generating strong and broad immune responses against the virus causing the disease.
Friday, November 07, 2014
Investment In Cancer Research At Oxford University
Centre for Molecular Medicine to focus on cancer genomics and molecular diagnostics, through a partnership with the Chan Soon-Shiong Institute.
Friday, October 24, 2014
A-maize-ing Double Life of a Genome
Study findings could help current efforts to improve existing crop varieties.
Tuesday, July 15, 2014
Genetic Tracking Identifies Cancer Stem Cells in Patients
The gene mutations driving cancer have been tracked for the first time in patients back to a distinct set of cells at the root of cancer – cancer stem cells.
Friday, May 16, 2014
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos